US 8541475
MAO-B inhibitors useful for treating obesity
granted A61PA61P25/00A61P3/00
Quick answer
US patent 8541475 (MAO-B inhibitors useful for treating obesity) held by Jenrin Discovery, LLC expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P25/00, A61P3/00, A61P3/04, A61P3/10